Dx&Vx signed a
memorandum of understanding on industry-university-research cooperation with
the Hanyang Institute of Bioscience and Biotechnology (HY-IBB) on Tuesday.
Under the accord, Dx&Vx and HY-IBB will jointly operate NGS (Next Generation Sequencing) equipment of the genome core and collaborate to develop mRNA-based therapeutics, vaccines, and next-generation biopharmaceuticals.
